Confounding factors of primary venous thromboses and embolisms associated with reproductive behavior of women


Cite item

Full Text

Abstract

Objective. To identify the major confounding factors of primary venous thromboses and embolisms associated with reproductive behavior of women. Subjects and methods. Retrospective analysis of risk factors for venous thromboembolic events (VTEEs) was made in 53 reproductive-aged (18-45-year-old) women with no history of severe somatic diseases and thromboses. Results. In 67.9% of the patients, the major triggers of primary VTEEs were the use of combined oral contraceptive (COC) pills (43.4%) and pregnancy/postpartum (24.5%). The most common cofactors were lower extremity varices (79.2%), over 35 years of age (62.4%), a sedentary lifestyle (60.4%), smoking (33.9%), obesity (33.9%), and positive family history of thromboses/genetically verified thrombophilia (20.8%). The mean number of background risk factors was 3.4±0.1 in COC users, 3.7±0.2 in pregnant women, and 5.0±0.1 in puerperas. Conclusion. When prescribing COC pills, planning, and managing pregnancy/postpartum, it is necessary to keep in mind that the risk of VTEEs is increased, to thoroughly assess the already existing risk factors, and to take every measure for their prevention.

About the authors

T E Belokrinitskaya

Chita State Medical Academy of the Ministry of Health of the Russian Federation

Email: tanbell24@mail.ru
д-р мед. наук, проф., зав. каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС ГБОУ ВПО ЧГМА 672090, Russian Federation, Chita, ul. Gor'kogo, d. 39a

N I Frolova

Chita State Medical Academy of the Ministry of Health of the Russian Federation

Email: taasyaa@mail.ru
канд. мед. наук, ассистент каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС ГБОУ ВПО ЧГМА 672090, Russian Federation, Chita, ul. Gor'kogo, d. 39a

E V Galygin

Regional Clinical Hospital

зав. отд-нием оперативной гинекологии ГУЗ ККБ 672038, Russian Federation, Chita, ul. Kokhanskogo, d. 7a

D B Nardin

Regional Clinical Hospital

зав. кардиохирургическим отд-нием ГУЗ ККБ по акушерству и гинекологии 672038, Russian Federation, Chita, ul. Kokhanskogo, d. 7a

E Yu Morozov

City Clinical Hospital №1

врач-ангиохирург хирургического отд-ния №2 ГУЗ ГКБ №1 672039, Russian Federation, Chita, ul. Lenina, d. 8

References

  1. Venous thromboembolism in women: a specific reproductive health risk. ESHRE Capri Workshop Group. Hum Reprod Update 2013; 19 (5): 471-82.
  2. Say L, Chou D, Gemmill A et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health 2014; 2 (6): 323-33.
  3. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010; 4 (2).
  4. Gourbil M, Grandvuillemin A, Beyens M.N et al. Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross - sectional observational study in 30 French public hospitals. Drug Saf 2014; 37 (4): 269-82.
  5. Heit J.A. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015; 12 (8): 464-74.
  6. Профилактика венозных тромбоэмболических осложнений в акушерстве и гинекологии. Клинические рекомендации (прото кол) утв. МЗ РФ 27 мая 2014 года №15-4102-3792. М., 2014.
  7. Dinger J, Heinemann L.A, Kühl-Habich D. The safety of a drospirenone containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women - years. Contraception 2007; 75 (5): 344-54.
  8. Hormonal Contraception and Risk of Venous Thromboembolism (VTE). Position statement. SOGC.19February2013.6p. https://docviewer. yandex.ru/r.xml?sk=56f543ccbba21f958ba121e8a866e60c&url=http%3 A%2F%2Fsogc.org%2Fwp-content%2Fuploads%2F2013%2F04%2 FmedHormonalContraceptionVTE1302192.pdf
  9. Petersen J.F, Bergholt T, Nielsen A.K et al. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Danish nationwide historical cohort 1995-2009. Thromb Haemost 2014; 112 (1): 73-8.
  10. Squizzato A, Van Zaane B, Gerdes V.E, Büller H.R. The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis. Semin Thromb Hemost 2011; 37 (1): 41-8.
  11. Kyriakakis N, Lynch J, Ajjan R, Murray R.D. The effects of pituitary and thyroid disorders on haemostasis: potential clinical implications. Clin Endocrinol (Oxf) 2016; 84 (4): 473-84.
  12. Wahlberg J, Tillmar L, Ekman B et al. Effects of prolactin on platelet activation and blood clotting. Scand J Clin Lab Invest 2013; 73 (3): 221-8.
  13. Van Zaane B, Squizzato A, Reuwer A.Q et al. Prolactin and Venous Thrombosis Indications for a Novel Risk Factor? Arterioscler Thromb Vasc Biol 2011; 31: 672-7.
  14. Bitzer J. Statement on combined hormonal contraceptives containing third - or fourth - generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. Eur J Contracept Reprod Health Care 2013; 18: 143-7.
  15. Bergendal A, Persson I, Odeberg J et al. Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes. Obstet Gynecol 2014; 124 (3): 600-9.
  16. Evans G, Sutton E.L. Oral contraception. Med Clin North Am 2015; 99 (3): 479-503.
  17. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/cyproterone_ethinylestradiol_107i/European_Commission_final_decision/WC500147176.pdf
  18. Медицинские критерии приемлемости методов контрацепции РФ. Адаптированный документ «Медицинские критерии приемлемости использования методов контрацепции ВОЗ, 4 издание, 2009». М., 2012.
  19. Кесарево сечение. Показания, методы обезболивания, хирургическая техника, антибиотикопрофилактика, ведение послеоперационного периода. Клинические рекомендации (протокол) утв. МЗ РФ 27 мая 2014 года №15-4102-3185. М., 2014.
  20. Jensen T.B, Gerds T.A, Grøn R et al. Risk factors for venous thromboembolism during pregnancy. Pharmacoepidemiol Drug Saf 2013; 22 (12): 1283-91.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).